Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.
Nat Med
; 20(9): 1027-34, 2014 Sep.
Article
in En
| MEDLINE
| ID: mdl-25173427
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Pyridines
/
Receptor, IGF Type 1
/
Receptor Protein-Tyrosine Kinases
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Nat Med
Journal subject:
BIOLOGIA MOLECULAR
/
MEDICINA
Year:
2014
Document type:
Article
Affiliation country:
Country of publication: